Stoke Therapeutics Inc (STOK)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Stoke Therapeutics Inc Azioni (STOK) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	91.29% 13.82	158.57	22.61	4.894	4.831
Operating Expenses	13.13% 41.12	47.33	36.27	34.90	34.17
Interest Income/Expense	200.00% 0.003	0.001	-	-	-
Benefits Costs and Expenses	16.01% 37.30	44.41	33.10	-	-
Costs And Expenses	16.01% 37.30	44.41	33.10	34.90	34.17
Operating Income/Loss	124.54% -27.30	111.24	-13.65	-30.00	-29.34
Nonoperating Income/Loss	30.85% 3.817	2.917	3.171	3.573	3.647
Income/Loss From Continuing Operations Before Tax	120.57% -23.48	114.16	-10.48	4.894	-25.70
Income Tax Expense/Benefit	100.00% -	1.278	-	-	-
Income/Loss From Continuing Operations After Tax	120.80% -23.48	112.88	-10.48	-26.43	-25.70
Net Income/Loss	120.80% -23.48	112.88	-10.48	-26.43	-25.70
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.85% 58.35	57.86	1.0179	56.34	55.77
Diluted Average Shares	1.76% 58.35	59.40	1.0179	56.34	55.77
Basic Earnings Per Share	120.51% -0.40	1.95	-0.17	-0.47	-0.46
Diluted Earnings Per Share	121.05% -0.40	1.90	-0.17	-0.47	-0.46
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.30

0.64%

GMAB

$28.71

0.35%

INCY

$101.57

8.65%

BNTX

$103.95

0.04%

ONC

$311.86

0.44%

INSM

$186.23

1.78%